Common data elements for clinical research in Friedreich's ataxia

Movement Disorders

Volumn 28, Issue 2, 2013, Pages 190-195

  Lynch, David R ^a   Pandolfo, Massimo ^b   Schulz, Jorg B ^c   Perlman, Susan ^d   Delatycki, Martin B ^e   Payne, R Mark ^f   Shaddy, Robert ^a   Fischbeck, Kenneth H ^g   Farmer, Jennifer ^h   Kantor, Paul ⁱ   Raman, Subha V ^j   Hunegs, Lisa ^k   Odenkirchen, Joanne ^g   Miller, Kristy ^k   Kaufmann, Petra ^g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f INDIANA UNIVERSITY   (United States)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^h Friedreich Ataxia Research Alliance   (United States)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j OHIO STATE UNIVERSITY   (United States)

^k KAI Research Inc   (United States)

more..

Author keywords

Cerebellum; Clinical measure; Dorsal root ganglion; Mitochondrion; NINDS Common Data Elements

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL RESEARCH; COMMON DATA ELEMENTS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILY HISTORY; FRIEDREICH ATAXIA; GAIT; GLUCOSE METABOLISM; HEALTH STATUS; HEART INJURY; HOLTER MONITORING; HUMAN; IMAGING; INFORMATION PROCESSING; INFORMATION SYSTEM; LABORATORY TEST; MEDICAL HISTORY; NATIONAL HEALTH ORGANIZATION; NEUROSCIENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; SOCIAL STATUS; VITAL SIGN;

ACADEMIC MEDICAL CENTERS; BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DEMOGRAPHY; FRIEDREICH ATAXIA; HEART DISEASES; HUMANS; INTERNATIONAL COOPERATION; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; NATIONAL INSTITUTES OF HEALTH (U.S.); NEUROLOGIC EXAMINATION; NEUROLOGY; PSYCHOMOTOR PERFORMANCE; REFERENCE STANDARDS; TELECOMMUNICATIONS; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME; UNITED STATES;

EID: 84874209253     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25201     Document Type: Article

References (37)

1. Harding AE.Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981;104:589-620.
2. Lynch DR, Farmer JM, Balcer LJ, Wilson RB.Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy. Arch Neurol 2002;59:743-747.
3. Fantus IG, Seni MH, Andermann E.Evidence for abnormal regulation of insulin receptors in Friedreich's ataxia. J Clin Endocrinol Metab 1993;76:60-63.
4. Finocchiaro G, Baio G, Micossi P, Pozza G, di Donato S.Glucose metabolism alterations in Freidreich's ataxia. Neurology 1988;38:1292-1296.
5. Khan RJ, Andermann E, Fantus IG.Glucose intolerance in Friedreich's ataxia: association with insulin resistance and decreased insulin binding. Metabolism 1986;35:1017-1023.
6. Coppola G, Coppola G, Marmolino D, et al. Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet 2009;18:2452-2461.
7. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM.Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2006;2:551-558.
8. Babcock M, de Silva, D, Oaks, R, et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 1997;276:1709-1712.
9. Rötig A, de Lonlay P, Chretien D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 1997;17:215-217.
10. Armstrong JS, Khdour O, Hecht SM.Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. FASEB J 2010;24:2152-2163.
11. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM.Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2006;2:551-558.
12. Boesch S, Sturm B, Hering S, Goldenberg H, Poewe W, Scheiber-Mojdehkar B.Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Ann Neurol 2007;62:521-524.
13. Lynch DR, Perlman SL, Meier T.A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Arch Neurol 2010;67:941-947.
14. Di Prospero NA, Baker A, Jeffries N, Fischbeck KH.Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol 2007;6:878-886.
15. Schulz JB, Di Prospero NA, Fischbeck K.Clinical experience with high-dose idebenone in Friedreich ataxia. J Neurol 2009;256(Suppl 1):42-45.
16. A, Heald S, Sciascia T.Use of an adaptive study design in single ascending-dose pharmacokinetics of A0001 (a-tocopherolquinone) in healthy male subjects. J Clin Pharmacol. 2012;52:65-76.
17. Boddaert N, Le Quan Sang KH, Rötig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 2007;110:401-408.
18. Marmolino D, Manto M, Acquaviva F, et al. PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia. PLoS One 2010;5:e10025.
19. Friedreich ataxia pipeline, 2011. www.curefa.org/pipeline.html. Accessed on December 17, 2011.
20. Tsou AY, Friedman LS, Wilson RB, Lynch DR.Pharmacotherapy for Friedreich ataxia. CNS Drugs 2009;23:213-223.
21. Adelson PD, Pineda J, Bell MJ, et al. Common data elements for pediatric traumatic brain injury: recommendations from the working group on demographics and clinical assessment. J Neurotrauma 2012;29:639-653.
22. Miller AC, Odenkirchen J, Duhaime AC, Hicks R.Common data elements for research on traumatic brain injury-pediatric considerations. J Neurotrauma 2012;29:634-638.
23. Loring DW, Lowenstein DH, Barbaro NM, et al.Common data elements in epilepsy research: development and implementation of the NINDS epilepsy CDE project. Epilepsia 2011;52:1186-1191.
24. Maas AI, Harrison-Felix CL, Menon D, et al. Common data elements for traumatic brain injury: recommendations from the interagency working group on demographics and clinical assessment. Arch Phys Med Rehabil 2010;91:1641-1649.
25. Friedman LS, Farmer JM, Perlman S, et al. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord 2010;25:426-432.
26. Lynch DR, Farmer JM, Tsou AY, et al. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology 2006;66:1711-1716.
27. Bürk K, Mälzig U, Wolf S, et al. Comparison of three clinical rating scales in Friedreich ataxia (FRDA). Mov Disord 2009;24:1779-1784.
28. Cano SJ, Hobart JC, Hart PE, Korlipara LV, Schapira AH, Cooper JM.International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia? Mov Disord 2005;20:1585-1591.
29. Lynch DR, Farmer JM, Wilson RL, Balcer LJ.Performance measures in Friedreich ataxia: potential utility as clinical outcome tools. Mov Disord 2005;20:777-782.
30. Lynch DR, Farmer JM, Rochestie D, Balcer LJ.Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia. J Neuroophthalmol 2002;22:270-274.
31. Collaborative Clinical Research Network in FA, 2011. www.curefa.org/network.html. Accessed on December 17, 2011.
32. European Friedreich ataxia consortium, 2011. www.e-facts.eu. Accessed on December 17, 2011.
33. Rajagopalan B, Francis JM, Cooke F, et al. Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia. Mov Disord 2010;25:846-852.
34. Meyer C, Schmid G, Görlitz S, et al. Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI. Mov Disord 2007;22:1615-1622.
35. Wilson CL, Fahey MC, Corben LA, et al. Quality of life in Friedreich ataxia: what clinical, social, and demographic factors are important? Eur J Neurol 2007;14:1040-1047.
36. Paulsen EK, Friedman LS, Myers LM, Lynch DR.Health-related quality of life in children with Friedreich ataxia. Pediatr Neurol 2010;42:335-337.
37. Epstein E, Farmer JM, Tsou A, et al. Health related quality of life measures in Friedreich ataxia. J Neurol Sci 2008;272:123-128.